와이바이오로직스

338840KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

10,200KRWMarket close of 10/27 (Tue)

Up +0.99%+100KRWMarket close of 10/27 (Tue)

Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)9,390KRWDown -7.94%

Preliminary · replaced once official KRX data for the same date is published

Open
10,160
High
10,400
Low
9,360
Day range
Day range low 9,360 high 10,400, open 10,160, close 10,200, previous close 10,100
Volume
8×10K shares
834.33 million KRW 1.60× the 20-session average

Market close of 10/27 (Tue)

Where it sits in the 1-year range

1-year close range 6,700 to 35,600 won, 12% up from the low

12% of the way up from the lowest close in 1 year (252 sessions) · -71.3% from the high

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27

Points to check

  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 2 are within the usual range

  • Daily move+0.99%usual range
  • Trading value1.6×usual range
See the full check report

Same sector · 바이오 R&D

Down -0.67%

· 26 of 64 stocks up, preferred shares excluded · trading value 190.2B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -12.6%Flat 0.00%51.8B KRW
올릭스Close over the last 20 sessions -11.8%Down -5.72%24.1B KRW
디앤디파마텍Close over the last 20 sessions -8.3%Up +0.37%14.0B KRW
리가켐바이오Close over the last 20 sessions -20.9%Down -1.54%12.1B KRW
페니트리움바이오Close over the last 20 sessions -4.2%Up +14.41%9.8B KRW

Schedule

  • Next data 10/29 (Thu) after 08:50

Related news

All news
Loading

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.